A new research collaboration between Danish diabetes giant Novo Nordisk and the Cambridge, USA-based firm Bluebird Bio will see the companies work together on c 9 October 2019
Swiss pharma giant Novartis has launched a new digital collaboration with Microsoft, a software company, aimed at boosting the firm’s artificial intelligence ca 1 October 2019
BenevolentAI, a UK artificial intelligence (AI) company focused on health and drug development, has announced a new collaboration, with Swiss giant Novartis. 6 September 2019
Pharma and other health companies are buying big into the artificial intelligence (AI) space, and the UK’s Health Secretary has now given this technology a majo 8 August 2019
A company that calls itself the world-leading AI-driven drug discovery company has entered into a collaboration with Rallybio, a privately-held development-stag 23 July 2019
IBM Watson Health has seen that being thought of as a pioneering company in applying artificial intelligence (AI) in healthcare can have its pros and cons, from 2 July 2019
Merck & Co is to participate in a US Food and Drug Administration (FDA) pilot program that uses blockchain technology to improve the way medicines are identifie 13 June 2019
In a previous incarnation, Boehringer Ingelheim chief financial officer Michael Schmelmer spearheaded a bold approach to innovation which could bear digital fru 10 May 2019
Japanese firms Eisai and Allm have agreed terms for a capital and business alliance agreement related to ICT digital health solutions and regional medical treat 9 May 2019
At its annual general meeting in Frankfurt am Main, Merck KGaA outlined plans to secure future growth, including ambitious goals in the contract manufacturing s 26 April 2019
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.